Tuesday's Top Insider Moves: Alumis Buys Surge, PennyMac Director Sells
Alumis Insider Bought Shares Worth $1,477,312, According to a Recent SEC Filing
Acelyrin Urges Stockholders to Vote for Proposed Merger With Alumis
H.C. Wainwright Maintains Alumis(ALMS.US) With Buy Rating, Maintains Target Price $14
Acelyrin Gains as Trium Capital Rebuffs M&A Deal With Alumis
Alumis | 10-K/A: Annual report (Amendment)
H.C. Wainwright Maintains Alumis(ALMS.US) With Buy Rating, Cuts Target Price to $14
Alumis Is Maintained at Buy by HC Wainwright & Co.
Alumis Analyst Ratings
Analysts Offer Insights on Materials Companies: BASF SE (OtherBASFY) and Alumis Inc. (ALMS)
Express News | Alumis Inc. : H.c. Wainwright Cuts Target Price to $14 From $15
Alumis Raises Share Consideration for Acelyrin Acquisition
Express News | Alumis Inc - Expects Runway to Fund Operations Into 2027
Express News | Alumis Inc - ACELYRIN Stockholders to Receive 0.4814 Shares of Alumis per Share
Press Release: Alumis and ACELYRIN Announce Amended Merger Agreement
12 Health Care Stocks Moving In Monday's Intraday Session
Hyatt Hotels, THOR Industries And Other Big Stocks Moving Lower On Monday
Alumis Down Over 31%, on Track for Record Percent Decrease -- Data Talk
Top 3 Health Care Stocks That May Crash In Q2
With Alumis Up 78%, Insider Buyers Count Their Returns